Literature DB >> 20392979

Sporothrix schenckii meningitis in AIDS during immune reconstitution syndrome.

Maria Clara Gutierrez Galhardo1, Marcus Tulius T Silva, Marco Antonio Lima, Estevão Portela Nunes, Luiz Eduardo C Schettini, Rodrigo Fernandes de Freitas, Rodrigo de Almeida Paes, Elizabeth de Sousa Neves, Antonio Carlos Francesconi do Valle.   

Abstract

Sporotrichosis is a fungal disease usually restricted to the cutaneous and lymphatic systems. Visceral involvement is unusual. To date, only 21 cases of sporotrichosis meningitis have been reported, some of these associated with immunosuppression. According to the reported cases, difficulty establishing the correct diagnosis is almost the rule which, undoubtedly, is associated with a worse prognosis. In this report, two HIV infected patients are described who developed meningitis due to Sporothrix schenckii associated with immune reconstitution inflammatory syndrome. This is the first report of sporotrichosis meningitis associated with immune reconstitution inflammatory syndrome in AIDS patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20392979     DOI: 10.1136/jnnp.2009.173187

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  12 in total

1.  Immune response against Sporothrix schenckii in TLR-4-deficient mice.

Authors:  Micheli Fernanda Sassá; Lucas Souza Ferreira; Livia Carolina de Abreu Ribeiro; Iracilda Zeppone Carlos
Journal:  Mycopathologia       Date:  2012-07       Impact factor: 2.574

2.  The Upside of Bias: A Case of Chronic Meningitis Due to Sporothrix Schenckii in an Immunocompetent Host.

Authors:  Christine Hessler; Carol A Kauffman; Felicia C Chow
Journal:  Neurohospitalist       Date:  2016-04-05

3.  Molecular identification of Sporothrix clinical isolates in China.

Authors:  Ting-ting Liu; Ke Zhang; Xun Zhou
Journal:  J Zhejiang Univ Sci B       Date:  2014-01       Impact factor: 3.066

Review 4.  The impact of sporotrichosis in HIV-infected patients: a systematic review.

Authors:  José A S Moreira; Dayvison F S Freitas; Cristiane C Lamas
Journal:  Infection       Date:  2015-02-21       Impact factor: 3.553

Review 5.  Sporothrix schenckii and Sporotrichosis.

Authors:  Mônica Bastos de Lima Barros; Rodrigo de Almeida Paes; Armando Oliveira Schubach
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

6.  Human sporotrichosis: recommendations from the Brazilian Society of Dermatology for the clinical, diagnostic and therapeutic management.

Authors:  Rosane Orofino-Costa; Dayvison Francis Saraiva Freitas; Andréa Reis Bernardes-Engemann; Anderson Messias Rodrigues; Carolina Talhari; Claudia Elise Ferraz; John Verrinder Veasey; Leonardo Quintella; Maria Silvia Laborne Alves de Sousa; Rodrigo Vettorato; Rodrigo de Almeida-Paes; Priscila Marques de Macedo
Journal:  An Bras Dermatol       Date:  2022-09-22       Impact factor: 2.113

7.  The predominance of alternatively activated macrophages following challenge with cell wall peptide-polysaccharide after prior infection with Sporothrix schenckii.

Authors:  Pamela Alegranci; Livia Carolina de Abreu Ribeiro; Lucas Souza Ferreira; Thais de Cássia Negrini; Danielle Cardoso Geraldo Maia; Aline Tansini; Amanda Costa Gonçalves; Marisa Campos Polesi Placeres; Iracilda Zeppone Carlos
Journal:  Mycopathologia       Date:  2013-05-18       Impact factor: 2.574

8.  Recombinant Phage Elicits Protective Immune Response against Systemic S. globosa Infection in Mouse Model.

Authors:  Feng Chen; Rihua Jiang; Yicun Wang; Mingji Zhu; Xu Zhang; Shuai Dong; Hongxi Shi; Li Wang
Journal:  Sci Rep       Date:  2017-02-06       Impact factor: 4.379

Review 9.  Immunopathogenesis of Human Sporotrichosis: What We Already Know.

Authors:  Fatima Conceição-Silva; Fernanda Nazaré Morgado
Journal:  J Fungi (Basel)       Date:  2018-07-31

10.  Therapeutic monoclonal antibody for sporotrichosis.

Authors:  Sandro R Almeida
Journal:  Front Microbiol       Date:  2012-11-28       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.